glp 1 birth defects GLP-1-Mediated Pregnancy and Neonatal Complications in Mice GLP-1 Receptor Agonists in Pregnancy

Ther JNPT

[DOI] [PubMed] [Google Scholar] 52.American Diabetes Association Professional Practice Committee

Understanding why coverage is challenging helps set realistic expectations

Patients receiving this medication should understand that it is a compounded preparation, meaning it is specifically prepared for individual use and is not a commercially manufactured pharmaceutical product

Cardiovascular Outcomes# EXSCEL Trial (Exenatide)# The EXSCEL trial (Holman et al., NEJM 2017) enrolled 14,752 patients with T2D (73.1% with prior CV disease): Primary MACE: HR 0.91 (95% CI 0.83-1.00, p=0.06 for superiority) Non-inferiority achieved